baber/WOPTO huggingface dataset:
Patent AU-2020254985-A1 (AU)
Title: Platelet membrane self-assembly nanobubble, and preparation method and application thereof
Inventor: YANG FANG
IPC: A61K49/22
Filed: 2020-02-24
Abstract: A platelet membrane self-assembly nanobubble, and a preparation method and application thereof. The preparation process comprises the following steps of: (1) performing repeated freezing and thawing on platelets, and obtaining a purified platelet membrane vesicle suspension after washing; and performing homogenization by means of a water bath ultrasonic effect; and (2) implementing self-assembly and reorganization of platelet membrane fragments on a gas-liquid interface after the homogenized platelet membrane vesicle suspension is subjected to ultrasonic cavitation fragmentation or gas-liquid mixing repeated extrusion, so as to construct and form a platelet membrane-coated nanobubble. The preparation method of the platelet membrane nanobubble is simple; and the nanobubble which has a nanometer size and retains the natural properties of the platelet membrane has high biocompatibility and vascular injury targeting, and can be used for ultrasound imaging diagnosis of a vascular injury part, thereby solving the problem of difficult targeted ultrasound imaging diagnosis of early small micro-lesions of cardio-cerebrovascular diseases.
Patent AU-2020290579-A1 (AU)
Title: Antibodies against MUC1 and methods of use thereof
Inventor: MARASCO WAYNE A
IPC: A61K47/68
Filed: 2020-06-15
Abstract: MUC1 is overexpressed in many cancers, including those of the lung, colon, breast, ovary, and pancreas. Aspects of the invention are directed towards the discovery of monoclonal antibodies and fragments thereof, such as a human single chain variable fragment (scFv), that recognizes human MUC1-SEA.
Patent AU-2020294219-A1 (AU)
Title: Composition for the prevention or treatment of respiratory diseases caused by fine dust comprising Agastache rugosa and licorice extract
Inventor: GEUM JEONG HO
IPC: A61P29/00
Filed: 2020-05-21
Abstract: The present invention relates to a composition for the prevention or treatment 
ofrespiratory diseases containing an Agastache rugosa and licorice extract as an active 
5 ingredient, and more specifically, the present invention relates to a composition for the 
prevention or treatment of respiratory diseases caused by fine dust containing an 
extract, in which Agastache rugosa and licorice are mixed at a weight ratio of 1:1 to 
6:1, as an active ingredient.  
The Agastache rugosa and licorice extract of the present invention has the 
10 efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung 
inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD1lb+ 
cell ratio reduction, and suppressing sputum production through inhibition of 
MUC5AC activity. In particular, since it is confirmed that the efficacy of the 
Agastache rugosa and licorice complex mixture is maximized at a specific mixing 
15 ratio, it can be widely utilized as a composition for the prevention or treatment of 
respiratory diseases caused by fine dust.
Patent AU-2020315338-A1 (AU)
Title: Acid-blocked pyrrolidine catalysts for polyurethane foam
Inventor: PHAM DIANNE
IPC: C07C211/02
Filed: 2020-07-14
Abstract: The present disclosure relates to acid-blocked pyrrolidine catalysts for use in a polyurethane formulation. The polyurethane formulation includes the acid-blocked pyrrolidine catalyst, a compound containing an isocyanate functional group, an active hydrogen-containing compound and a halogenated olefin compound. The use of such acid-blocked pyrrolidine catalysts show surprisingly low reactivity with halogenated olefin compounds yet sufficient reactivity to catalyze polyurethane formation.
Patent AU-2020352890-A1 (AU)
Title: Dynamic typesetting
Inventor: KELLUM SCOTT
IPC: G06F3/0484
Filed: 2020-09-04
Abstract: A computer implemented method for providing a dynamic typesetting package. The method receives a request from a user for a typesetting package, and the typesetting package includes one or more font, and one or more rendering rules for defining typesetting for various elements of content across layout contexts. In response to a requested typesetting package, the method provides a link to the user. The link references the requested typesetting package. The method matches at least a portion of the elements of the content to one or more parameters in the one or more rendering rules. The one or more rendering rules, in response to an execution by a computerized device having a display, the content is dynamically typeset for the display.
Patent AU-2020359305-A1 (AU)
Title: Air-boom spreader for particulate material
Inventor: GRAY GEOF J
IPC: A01C15/00
Filed: 2020-07-13
Abstract: An air-boom spreader has a hopper for containing particulate material, a metering device having a plurality of sluices, a plurality of outlets transversely spaced-apart on a boom in a direction perpendicular to the direction of travel of the spreader, and a plurality of air lines connecting the plurality of sluices to the plurality of outlets for conveying the particulate material in an air stream from the plurality of sluices to the plurality of outlets. The spreader has more than twice as many outlets as sluices, and the plurality of outlets has an innermost outlet, an outermost outlet and at least three other outlets between the innermost outlet and the outermost outlet whereby each of the innermost outlet and the outermost outlet are supplied with half as much of the particulate material as each of the at least three other outlets.
Patent AU-2020361110-A1 (AU)
Title: Nasal spray injection nozzle and rest product for administration of nasal drops
Inventor: KAMISHITA TAIZOU
IPC: A61M11/08
Filed: 2020-09-30
Abstract: Provided is a nasal spray injection nozzle capable of further improving drug delivery to a target site within a nasal cavity. This nasal spray injection nozzle has: a distal end portion having a nozzle injection hole; and a nose rest that can be brought into contact with a portion around a nostril.
Patent AU-2020364034-A1 (AU)
Title: Non-dairy crumb and method for its manufacture
Inventor: WILLBERG MONIKA
IPC: A23G1/34
Filed: 2020-10-12
Abstract: The present invention relates to a method for preparing a non-dairy crumb for various food applications. In particular, the present invention relates to a grain-based crumb, to a method for preparing said crumb, to food products containing the grain-based crumb, as well as to the use of the grain-based crumb in various food applications, such as confectionery products and sweet bakery products. The invention also relates to a method for decreasing grainy flavours of grain-based products.
Patent AU-2020368344-A1 (AU)
Title: Cannabidiol adjuvant therapy for treatment of disc degenerative disease
Inventor: O'HEERON PETE
IPC: A61K31/165
Filed: 2020-10-13
Abstract: Disclosed is the utilization of cannabidiol, either through systemic and/or local administration, for use as an adjuvant in treatments of disc degenerative disease. In some embodiments, cannabidiol is utilized to enhance therapeutic and/or regenerative activities of fibroblasts. In other embodiments, cannabidiol is utilized to augment reparative effects of other regenerative cells including monocytes, mesenchymal stem cells, and/or hematopoietic stem cells. In some embodiments cannabidiol is utilized in the culture media of regenerative cells prior to administration of said cells.
Patent AU-2020457254-A1 (AU)
Title: Quantum operation control layout for a quantum computation
Inventor: LECHNER WOLFGANG
IPC: G06F30/392
Filed: 2020-07-09
Abstract: According to an embodiment, a method of determining a quantum operation control layout for a quantum computation on a quantum system is provided. The quantum computation is to be carried out on constituents of the quantum system arranged in accordance with a mesh. Vertices of the mesh represent possible sites for the constituents of the quantum system. Each cell of the mesh indicates that quantum interactions between constituents of the quantum system arranged in that cell are possible during the quantum computation. The method includes providing a data set including data representing hyperedges of a hypergraph. The method includes determining a set of generalized cycles. The generalized cycles contain hyperedges of the hypergraph or contain hyperedges of an enlarged hypergraph. The enlarged hypergraph at least includes the hyperedges of the hypergraph and an additional hyperedge. Therein, a maximal length of generalized cycles of the set of generalized cycles is not greater than a maximal vertex number of the cells of the mesh. The method includes determining a mesh mapping that maps data representing the hyperedges of the hypergraph or of the enlarged hypergraph to the vertices of the mesh. Therein, each generalized cycle of a constraining subset of the set of generalized cycles consists of hyperedges mapped to a cell of the mesh. The method includes generating the quantum operation control layout. The quantum operation control layout includes data indicating layout vertices of the mesh. Each layout vertex corresponds to a hyperedge mapped according to the mesh mapping. The layout includes data indicating layout vertex sets. Each layout vertex set consists of layout vertices within a cell of the mesh that correspond to a generalized cycle of the constraining subset of generalized cycles.
Patent WO-2022067374-A1 (WO)
Inventor: DANTANARAYANA MUDITHA
IPC: A61M16/20
Filed: 2021-08-27
Abstract: The technology relates to a variable flow vent assembly for a conduit mask configured to deliver a flow of breathable gas at a positive pressure to an airway entrance of a patient and allow a flow of exhaled gas from the airway of the patient to exit the vent assembly to ambient. The variable flow vent assembly is further configured to include a valve, wherein the valve is arranged to allow for the regulation of the flow of breathable gas to the patient and the regulation of the vent flow rate of exhaled gas leaving the vent assembly to ambient. By changing certain characteristics of the valve and by tuning the valve through variants in design, the resultant vent flow rate for a given air pressure can be altered in order to obtain the best treatment outcome for the patient's individual requirements.
Patent AU-2021203500-A1 (AU)
Title: Integrating a wheel between reels of a slot game
Inventor: COPPOLA ROBERTO
IPC: A63F13/50
Filed: 2021-05-28
Abstract: A slot game integrates a wheel positioned between one or more preceding reels and one or 
more subsequent reels. The game controller may dynamically populate the wheel with symbols 
from the outcome of the one or more preceding reels. The controller determines a symbol outcome 
for the wheel and performs pay evaluation based on applying the symbol outcome as positioned 
between the one or more preceding reel outcomes and the one or more subsequent reel outcomes.  
The game controller may perform cross-symbol mapping to map the symbol outcome to a 
subsequent reel.  
17683886 1 (GHMatters) P116190.AU
3/3 
300 
PLAYER INPUT(S) 
302 
304 UISYSTEM 308 312 
GAME PLAY UI BONUS GAME PLAY UI 
306A p 306N p 310A ( 310N 
GAME GAME BONUS BONUS MULTIPLAYER 
PLAY UI 000 PLAY UI GAME PLAY oes GAME PLAY UI 
ELEMENT ELEMENT UI ELEMENT UI ELEMENT 
RGCLRNG CALLS RNG CALL 314 
GAME PROCESSING BACKEND SYSTEM 316 
RNG ENGINE 
318 ( 319A 319N 
GAMING NON- *eo NON
RNG GAMING GAMING 
RNG RNG 
RNG OUTCOMES 320
RNG CONVERSION ENGINE 
322A ( 322B 322N 
LOOKUP LOOKUP ** LOOKUP 
TABLE TABLE TABLE 
UI OUTCOMES I 
FIG. 3
Patent AU-2021209220-A1 (AU)
Title: Compositions And Methods For Treatment Of Diseases
Inventor: PRENDERGAST PATRICK
IPC: A61K39/02
Filed: 2021-07-27
Abstract: A method for treating or preventing laminitis is provided comprising administering to an 
ungulate a therapeutically or prophylactically effective amount of a camelid protease 
inhibitor. Typically the ungulate is a horse and the camelid protease inhibitor is an inhibitor of 
equine metalloproteinases and equine serine proteases. The inhibitor may be isolated from 
blood from healthy camelid or may be generated by inoculating camelid with purified equine 
metalloproteinase enzymes and serine proteases or with snake venom metalloproteinases, 
such as those obtained from Bothropsjararaca. The inhibitor may a homodimer antibody or 
an antigen binding fragment of same. Also provided are compositions comprising such 
camelid protease inhibitors.
Patent AU-2021221208-A1 (AU)
Title: Signaling receiving method, signaling transmitting method, and device
Inventor: ZHANG SHUJUAN
IPC: H04W36/00
Filed: 2021-02-05
Abstract: Disclosed are a signaling receiving method, a signaling transmitting method, and a device. The signaling receiving method comprises: receiving a first signaling, wherein the first signaling comprises a first-type parameter corresponding to a target element; the first-type parameter comprises at least one of the following parameters: a physical cell identifier, a mobile measurement reference signal, and the sequence parameter of a synchronization signal; the target element comprises at least one of the following elements: a serving cell, a serving cell group, a bandwidth part (BWP), a BWP group, an information element, an information element group, a transmission configuration indication (TCI) state, and a TCI state group; and the information element comprises at least one of a channel and a signal.
Patent AU-2021268626-A1 (AU)
Title: Method and system for shared transport
Inventor: GODIL HASRAT
IPC: G06Q10/04
Filed: 2021-11-15
Abstract: A transport arrangement system operates to provide a service, which can receive a transport pool request 
from a rider. The transport pool request can specify a set of parameters, including a pickup location and a 
drop-off location. A candidate set of transport providers are identified that satisfy one or 
more criterion, including a criterion of proximity relative to the pickup location. One of the candidate set of 
drivers is selected to provide a transport pool for the rider. The selection can be based at least in part on 
determining which individual drivers of the candidate set satisfy one or more constraints, including a first 
constraint that relate to a predicted trip completion time for the rider.
WO 2017/087565 PCT/US2016/062344 
1/6 
0 
0 
>) LL.  
E 
0 
o O~ 
a00 
00 
E a) 
E Z 
00 
U)) 
_Y 0
n 
0 .  
U)U 
>6
Patent AU-2021273111-A1 (AU)
Title: System for mounting a rollable screen
Inventor: VANHOUTTE STEVEN
IPC: E06B9/44
Filed: 2021-04-23
Abstract: A system (100) for mounting a reliable screen, comprising: • - a screen roll (200) comprising an end having a hollow tube (101); • - a coupling piece (102) comprising: • - a neck element (104), comprising a sleeve (300) adapted to be positioned in axial direction inside the tube (101), wherein contact surfaces (302) comprised in the sleeve (300) contact the tube (101), and wherein recess surfaces (301) comprised in the sleeve (300) define axial channels (800) between the neck element (104) and the tube (101); • - a transitional element (105) fixedly connected to the neck element (104), • - one or multiple anchoring elements (103), adapted to fasten the neck element (104) detachably to the tube (101), wherein in an anchored state the anchoring elements (103) are clamped inside the axial channels (800), with an even clamping along the axial direction (204).
Patent AU-2021275541-A1 (AU)
Title: Liquid formulation of long-acting conjugate of GLP-2
Inventor: HONG SUNG HEE
IPC: A61K47/64
Filed: 2021-05-24
Abstract: The present invention relates to a liquid formulation of a long-acting conjugate of glucagon-like peptide-2 (GLP-2), and a method for producing same.
Patent AU-2021275623-A1 (AU)
Title: Substituted pyrazolyl compounds and methods of use thereof
Inventor: POWELL DAVID ANDREW
IPC: C07D417/04
Filed: 2021-05-17
Abstract: Provided herein are compounds, compositions and methods useful for inhibiting lactate dehydrogenase (LDH) activity and for the treatment, prevention and amelioration of one or more symptoms of diseases or disorders related to LDH activity, or the accumulation of oxalate, including hyperoxaluria.
Patent AU-2021288667-A1 (AU)
Title: Control method and apparatus for warehouse robot, and robot and warehouse system
Inventor: LI HUIXIANG
IPC: B65G1/04
Filed: 2021-06-29
Abstract: A control method and apparatus for a warehouse robot (110), and a robot and a warehouse system (100). The method comprises: acquiring a container scheduling instruction for a first target container, wherein the container scheduling instruction comprises a container type of the first target container; determining a container attitude recognition algorithm according to the container type of the first target container, and recognizing attitude information of the first target container on the basis of the container attitude recognition algorithm; and according to the attitude information, controlling the warehouse robot (110) to retrieve the first target container. With regard to different types of containers, corresponding attitude recognition algorithms are used to determine attitude information of the containers, and different types of containers are automatically retrieved on the basis of the attitude information, thereby improving the application range and efficiency of automatic cargo retrieval of the warehouse robot (110).
Patent AU-2021308081-A1 (AU)
Title: Attention-based neural network to predict peptide binding, presentation, and immunogenicity
Inventor: LIU KAI
IPC: G16B40/20
Filed: 2021-07-16
Abstract: Embodiments disclosed herein generally relate to using an attention-based machine learning model to generate an output that includes at least one of an interaction prediction for a target interaction, an interaction affinity prediction, or an immunogenicity prediction relating to a target interaction for a corresponding peptide-immunoprotein complex (IPC) combination. A target interaction may be between a peptide and an immunogenicity complex (IPC) such as, for example, a major histocompatibility complex (MHC), a T cell receptor (TCR), or both. A pharmaceutical composition may be identified, manufactured, and/or used that includes one or more peptides for which one or more target interactions are predicted to be more likely. Methods of treatment may be defined and/or used that include administration of such a pharmaceutical composition.
Patent AU-2021310494-A1 (AU)
Title: Conversion of plastics to monomers by pyrolysis
Inventor: BARGER PAUL T
IPC: B09B3/00
Filed: 2021-07-08
Abstract: A plastic pyrolysis process that can produce high yields of ethylene, propylene and other light olefins from waste plastics is disclosed. The plastic feed is pyrolyzed at a low-temperature pyrolysis process and subsequently pyrolyzed in a high-temperature pyrolysis process directly to monomers, such as ethylene and propylene. Insufficiently pyrolyzed product from the low-temperature pyrolysis process can be fed to the high-temperature pyrolysis process while preserving the desired low-temperature product monomers.
Patent AU-2021332979-A1 (AU)
Title: Method and apparatus for transmitting or receiving data using cooperative communication in wireless communication system
Inventor: JUNG EUICHANG
IPC: H04B7/024
Filed: 2021-08-26
Abstract: The present disclosure relates to a 5th generation (5G) or pre-5G communication system for supporting a higher data transmission rate than that of a beyond-4th generation (4G) communication system such as long-term evolution (LTE). The present disclosure relates to inter-cell cooperative transmission through a multi-transmission reception point (TRP) in a wireless or communication system. An operation method of a terminal comprises the steps of: receiving configuration information related to a multi-TRP; checking whether inter-cell multi-TRP transmission is configured on the basis of the configuration information; when the inter-cell multi-TRP transmission is configured, checking a control resource set (CORESET) for the multi-TRP on the basis of the configuration information; receiving downlink control information (DCI) for the multi-TRP through the CORESET; and receiving data from the multi-TRP on the basis of the DCI.
Patent AU-2021339962-A1 (AU)
Title: Fgfr inhibitor combination therapies
Inventor: SANTIAGO-WALKER ADEMI
IPC: A61K45/06
Filed: 2021-09-13
Abstract: Described herein are methods of treating cancer comprising administering a fibroblast growth factor receptor (FGFR) inhibitor in combination with an epidermal growth factor receptor (EGFR) inhibitor, a Cyclin D1 (CCND1) inhibitor or a BRAF inhibitor to a patient in need of cancer treatment, wherein the patient harbors at least one FGFR2 genetic alteration or FGFR3 genetic alteration and at least one EGFR, CCND1 or BRAF genetic alteration, respectively. Also described herein are methods of predicting duration of progression-free survival (PFS) or overall survival (OS) in a patient, in particular a human patient, having cancer, in particular in a patient on treatment with an FGFR inhibitor, the method comprising evaluating a biological sample from the patient for the presence of at least one FGFR2 genetic alteration or FGFR3 genetic alteration and at least one EGFR, CCND1, or BRAF genetic alteration, wherein the presence of at least one FGFR2 genetic alteration or FGFR3 genetic alteration and at least one EGFR, CCND1, or BRAF genetic alteration indicates a shorter duration of PFS or a shorter duration of OS, relative to a patient, in particular a human patient, having cancer who does not harbor at least one EGFR, CCND1, or BRAF genetic alteration, respectively, or relative to a patient, in particular a human patient, having cancer who does not harbor at least one FGFR2 genetic alteration or FGFR3 genetic alteration and at least one EGFR, CCND1, or BRAF genetic alteration, respectively. Additionally, described herein are methods of improving PFS or OS in a patient with cancer relative to a patient with cancer who was not receiving treatment with an FGFR inhibitor in combination with an EGFR inhibitor, a CCND1 inhibitor or a BRAF inhibitor, said method comprising providing to said patient an FGFR inhibitor in combination with an EGFR inhibitor, a CCND1 inhibitor or a BRAF inhibitor, wherein said patient harbors at least one FGFR2 genetic alteration or FGFR3 genetic alteration and at least one EGFR, CCND1, or BRAF genetic alteration, respectively.
Patent AU-2021340200-A1 (AU)
Title: Foodstuffs having improved digestion properties
Inventor: DOMONEY CLAIRE
IPC: C07K14/415
Filed: 2021-09-08
Abstract: The invention relates to methods for determining if a pea variety or a product derived from that pea variety has improved digestion properties. The invention also relates to methods of improving the digestion property of a pea, as well as method of making such plants.
Patent AU-2021355605-A1 (AU)
Title: Motorcycle helmet
Inventor: HIGASHIDE Kosuke
IPC: A42B3/00
Filed: 2021-07-16
Abstract: A motorcycle helmet is provided which can drastically improve motorcycle 
driving technique and skill. A motorcycle helmet 1 of the present invention is 
provided with a helmet body 11 configured to partially or entirely cover a head of a 
wearer and having an opening 14 in front of a face surface of the wearer, and a gaze 
corrector 13 provided in a center of a frame 15 forming the opening 14 in the helmet 
body 11 to divide the opening 14 and being an angular columnar body and enabling 
correction of a gaze of the wearer. The gaze corrector 13 has mutually different colors 
on a facing surface 13a facing the wearer, a right side surface 13b located to the right of 
the facing surface 13a and a left side surface 13c located to the left of the facing surface 
13a, and the gaze corrector 13 divides a field of view of the wearer into a right field of 
view and a left field of view.